Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead

被引:51
作者
Kumar, Arun [2 ]
Chang, Biao [3 ]
Xagoraraki, Irene [1 ]
机构
[1] Michigan State Univ, Dept Civil & Environm Engn, E Lansing, MI 48824 USA
[2] Indian Inst Technol, Dept Civil Engn, New Delhi 110016, India
[3] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA
关键词
human health; pharmaceuticals; mixture toxicity; risk assessment; uncertainty; WASTE-WATER; SURFACE; MIXTURE; CARBAMAZEPINE; ENVIRONMENT; CHEMICALS; EXPOSURE; RIVERS;
D O I
10.3390/ijerph7113929
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
This study identified existing issues related to quantitative pharmaceutical risk assessment (QPhRA, hereafter) for pharmaceuticals in water and proposed possible solutions by analyzing methodologies and findings of different published QPhRA studies. Retrospective site-specific QPhRA studies from different parts of the world (U. S. A., United Kingdom, Europe, India, etc.) were reviewed in a structured manner to understand different assumptions, outcomes obtained and issues, identified/addressed/raised by the different QPhRA studies. Till date, most of the published studies have concluded that there is no appreciable risk to human health during environmental exposures of pharmaceuticals; however, attention is still required to following identified issues: (1) Use of measured versus predicted pharmaceutical concentration, (2) Identification of pharmaceuticals-of-concern and compounds needing special considerations, (3) Use of source water versus finished drinking water-related exposure scenarios, (4) Selection of representative exposure routes, (5) Valuation of uncertainty factors, and (6) Risk assessment for mixture of chemicals. To close the existing data and methodology gaps, this study proposed possible ways to address and/or incorporation these considerations within the QPhRA framework; however, more research work is still required to address issues, such as incorporation of short-term to long-term extrapolation and mixture effects in the QPhRA framework. Specifically, this study proposed a development of a new. mixture effects-related uncertainty factor. for mixture of chemicals (i.e., mixUF(composite)), similar to an uncertainty factor of a single chemical, within the QPhRA framework. In addition to all five traditionally used uncertainty factors, this uncertainty factor is also proposed to include concentration effects due to presence of different range of concentration levels of pharmaceuticals in a mixture. However, further work is required to determine values of all six uncertainty factors and incorporate them to use during estimation of point-of-departure values within the QPhRA framework.
引用
收藏
页码:3929 / 3953
页数:25
相关论文
共 36 条
[1]   Screening analysis of human pharmaceutical compounds in US surface waters [J].
Anderson, PD ;
D'Aco, VJ ;
Shanahan, P ;
Chapra, SC ;
Buzby, ME ;
Cunningham, VL ;
Duplessie, BM ;
Hayes, EP ;
Mastrocco, FJ ;
Parke, NJ ;
Rader, JC ;
Samuelian, JH ;
Schwab, BW .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2004, 38 (03) :838-849
[2]  
[Anonymous], EPA822B00004
[3]   REFERENCE DOSE (RFD) - DESCRIPTION AND USE IN HEALTH RISK ASSESSMENTS [J].
BARNES, DG ;
DOURSON, M .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1988, 8 (04) :471-486
[4]   Pharmaceuticals and Endocrine Disrupting Compounds in US Drinking Water [J].
Benotti, Mark J. ;
Trenholm, Rebecca A. ;
Vanderford, Brett J. ;
Holady, Janie C. ;
Stanford, Benjamin D. ;
Snyder, Shane A. .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2009, 43 (03) :597-603
[5]   Human health risk assessments for three neuropharmaceutical compounds in surface waters [J].
Bercu, Joel P. ;
Parke, Nell J. ;
Fiori, Janice M. ;
Meyerhoff, Roger D. .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2008, 50 (03) :420-427
[6]   Pharmaceuticals in the environment - A human risk? [J].
Christensen, FM .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1998, 28 (03) :212-221
[7]   Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid [J].
Cleuvers, M .
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2004, 59 (03) :309-315
[8]  
CLEUVERS M, 1986, 630R98002 EPA
[9]   Antibacterial Medication Use During Pregnancy and Risk of Birth Defects National Birth Defects Prevention Study [J].
Crider, Krista S. ;
Cleves, Mario A. ;
Reefhuis, Jennita ;
Berry, Robert J. ;
Hobbs, Charlotte A. ;
Hu, Dale J. .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2009, 163 (11) :978-985
[10]   Human health risk assessment of carbamazepine in surface waters of North America and Europe [J].
Cunningham, Virginia L. ;
Perino, Christopher ;
D'Aco, Vincent J. ;
Hartmann, Andreas ;
Bechter, Rudolf .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2010, 56 (03) :343-351